Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 12/20 | 0.65 |
| ▸ | PNMT | P11086 | 2/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20563034 | 0.80 | TAAR1 (0.53) | TAAR1PNMTHTR2AMAOBMAPK1 | |
| SCHEMBL2095375 | 0.80 | PNMT (0.65) | TAAR1PNMTCYP3A4MAPK1 | |
| SCHEMBL1570973 | 0.79 | TAAR1 (1.00) | TAAR1PNMTHTR2AMAOBCYP3A4 | |
| SCHEMBL30785390 | 0.79 | TAAR1 (1.00) | TAAR1PNMTHTR2AMAOBCYP3A4 | |
| SCHEMBL9482589 | 0.78 | TAAR1 (0.40) | TAAR1PNMTCYP3A4MAPK1 | |
| SCHEMBL8440317 | 0.76 | TAAR1 (0.39) | TAAR1PNMTCYP3A4MAPK1 | |
| SCHEMBL17552721 | 0.76 | TAAR1 (0.39) | TAAR1PNMTCYP3A4MAPK1 | |
| SCHEMBL10061111 | 0.76 | TAAR1 (0.39) | TAAR1PNMTCYP3A4MAPK1 | |
| SCHEMBL8310445 | 0.76 | TAAR1 (0.48) | TAAR1PNMTHTR2AMAOB | |
| SCHEMBL4465598 | 0.74 | CYP3A4 (0.43) | TAAR1PNMTCYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5593993-A | VIRICIDES FOR HTLV TREATMENT OF AIDS | MEDIVIR AB (SE) | 1997-01-14 | — | — | US | disclosed |